Fig. 1.
Tracheal "map" showing distribution and types of lesions in hamsters killed at start of retinoid treatment. Hamsters were exposed to 1.0% NMU for 18 times, twice a week. Each vertical column represents the trachea of one hamster. Numbers at bottom of column indicate the number of hamster. Numbers on left designate the individual tracheal rings. Horizontal lines indicate tracheal region (4th-10th rings) intentionally exposed. Mortality of NMU exposed hamsters treated with retinoids (18 times) Time after of Retinoid treatment (weeks) The effect of 2 retinoids, 13 cis retinoic acid and R011-1430, on tracheal tumor development in hamsters exposed to N-nitroso-N-methylurea (NMU) was tested. Hamsters were intratracheally exposed 18 times to 1.0% NMU, twice a week, by means of the previously reported tracheal tumor induction system, before the retinoids were administered in the diet. The experimental groups studied were as follows , 150 mg R011-1430 R011- , 75 mg RO 11-1430 mg 13 cis-retinoic acid/kg of control diet respectively, and control diet containing a Vitamin A 46 IU/g diet. As preliminary works, toxicity of retinoids, serum level of Vitamin A and early changes of tracheal epithelium induced by NMU were also studied. Although the preliminary experiments showed this experimental model was suitable for this kind of cancer prevention study , all three retinoid treated groups could not show a statistically significant inhibition of tumor development. However, we believe, that slight trends towards a reduced tumor incidence in the 150 mg ROni -1430/kg diet group showed a posibility that this retinoid could be a good "chemopreventional drug" for cancer, if handled effectively . The distribution of histologic tumor types seemed to be in favor of adeno and mixed adeno-epidermoiod tumors in the group treated with also 150 mg R011-1430 . Several possible explanations for failure of the 2 retinoids to inhibit tumor development in this study were discussed .
